Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets 05/02/2024			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

06-29	Tonix Pharmaceuticals Advances TNX-102 SL Into Phase 2 MDD Study	MT
06-29	Tonix Pharmaceuticals Holding Corp Announces First Patient Enrolled in Phase 2 Horizon Study of TNX-102 SL For Major Depressive Disorder	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	203.7	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	5.25%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	203.7	203.7	203.7
Change	-	-87.36%	5.35%	160.94%	214.02%	5.25%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-1.24x	-2.06x	-5.42x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0.1x	0.1x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	5.96x	2.58x	1.25x
EV / Revenue	-	-	0x	0x	0x	5.96x	2.58x	1.25x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-1.19x	-1.32x	-2.14x
EV / FCF	-	-	-	-	-	-1.02x	-0.99x	-1.2x
FCF Yield	-	-	-	-	-	-98.2%	-101%	-83.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-166,400	-65,400	-21,920	-176.6	-14.57	-10.27	-6.2	-2.36
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	34.18	78.93	163
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-171.7	-153.8	-95.22
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-170	-151.8	-85.5
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	228,928.00	7,796.00	1,289.60	32.98	15.62	12.78	12.78	12.78
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	15,941	-	-
Announcement Date	14/03/22	13/03/23	01/04/24	18/03/25	12/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,084B
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	634B
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	447B
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	330B
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	295B
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	285B
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	218B
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	199B
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	169B
Average	16.38x	6.59x	16.89x	2.39%	406.65B
Weighted average by Cap.	24.24x	8.02x	18.60x	1.95%